Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Allard, Julien"'
Autor:
Abegg VF; Division of Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Switzerland., Panajatovic MV; Division of Clinical Pharmacology & Toxicology, University Hospital, Basel, Switzerland., Mancuso RV; Division of Clinical Pharmacology & Toxicology, University Hospital, Basel, Switzerland., Allard JA; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland., Duthaler U; Division of Clinical Pharmacology & Toxicology, University Hospital, Basel, Switzerland., Odermatt A; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland., Krähenbühl S; Division of Clinical Pharmacology & Toxicology, University Hospital, Basel, Switzerland., Bouitbir J; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Switzerland. Electronic address: jamal.bouitbir@unibas.ch.
Publikováno v:
Toxicology letters [Toxicol Lett] 2024 Mar; Vol. 393, pp. 1-13. Date of Electronic Publication: 2024 Jan 14.
Autor:
Allard J; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Bucher S; Scribe Therapeutics, Alameda, California, USA., Ferron PJ; INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1317, Rennes, France., Launay Y; INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1317, Rennes, France., Fromenty B; INSERM, Univ Rennes, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1317, Rennes, France.
Publikováno v:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2024 Feb; Vol. 38 (1), pp. 152-167. Date of Electronic Publication: 2023 Sep 04.
Autor:
Allard J; INSERM, Univ. Rennes, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, Rennes, France., Le Guillou D; INSERM, Univ. Rennes, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, Rennes, France., Begriche K; INSERM, Univ. Rennes, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, Rennes, France., Fromenty B; INSERM, Univ. Rennes, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, Rennes, France. Electronic address: bernard.fromenty@inserm.fr.
Publikováno v:
Advances in pharmacology (San Diego, Calif.) [Adv Pharmacol] 2019; Vol. 85, pp. 75-107. Date of Electronic Publication: 2019 Feb 20.